The Watchman procedure, also known as left atrial appendage closure (LAAC), is a minimally invasive medical procedure designed to reduce the risk of stroke in individuals with atrial fibrillation (AFib). AFib is a common heart rhythm disorder characterized by irregular and rapid electrical signals ...
The WATCHMAN and WATCHMAN FLX Devices are permanent implants designed to close the left atrial appendage in the heart in an effort to reduce the risk of stroke. With all medical procedures there are risks associated with the implant procedure and the use of the device. The risks include but...
A lifetime of stroke risk reduction, without the lifelong risks of OACs. Learn how it works One Time. For a Lifetime. Protection against stroke risk. Protection against oral anticoagulant (OAC) bleed risk. The WATCHMAN Implant is the one-time, minimally invasive procedure that protects your ...
A lifetime of stroke risk reduction, without the lifelong risks of OACs. Learn how it works One Time. For a Lifetime. Protection against stroke risk. Protection against oral anticoagulant (OAC) bleed risk. The WATCHMAN Implant is the one-time, minimally invasive procedure that protects your ...
The WATCHMAN FLX and WATCHMAN FLX Pro Devices are permanent implants designed to close the left atrial appendage in the heart in an effort to reduce the risk of stroke. With all medical procedures there are risks associated with the implant procedure and the use of the device. The risks inclu...
The WATCHMAN FLX and WATCHMAN FLX Pro Devices are permanent implants designed to close the left atrial appendage in the heart in an effort to reduce the risk of stroke. With all medical procedures there are risks associated with the implant procedure and the use of the device. The risks inclu...
The WATCHMAN FLX and WATCHMAN FLX Pro Devices are permanent implants designed to close the left atrial appendage in the heart in an effort to reduce the risk of stroke. With all medical procedures there are risks associated with the implant procedure and the use of the device. The risks inclu...
Thanks to continuing innovation and advancement, the WATCHMAN Implant is offering more people than ever a safe, effective alternative to blood thinners should they need one. In a clinical trial, 96% of people were able to stop their blood thinner 45 days after the procedure to get the WATCHMAN...
“With the device redesign, we’ve improved the safety profile of the procedure substantially,” Freeman told TCTMD. That doesn’t necessarily change who is offered LAAO, but it may affect who is referred for the procedure by easing concerns about the associated risks in older, sometimes frail...
Its approval was supported by positive 12-month results from PINNACLE FLX, the US investigational device exemption study that demonstrated high closure rates and good safety, with few early major procedure-related safety events (0.5% at 7 days). At 1 year, effective closure—defined as peridevice...